Veterans Affairs Nephropathy in Diabetes - VA NEPHRON-D

Description:

The goal of the trial was to evaluate treatment with combination angiotensin-converting enzyme inhibitor (ACE-I) and angiotensin-receptor blocker (ARB) compared with ACE-I alone among patients with diabetic nephropathy.